Evidence map›Paper›PMID 26182377›Full record

ArticleBioscience reports2015

Cysteine-specific ubiquitination protects the peroxisomal import receptor Pex5p against proteasomal degradation.

Benjamin Schwartzkopff, Harald W Platta, Sohel Hasan, Wolfgang Girzalsky, Ralf Erdmann

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Mammalian pexophagy at a glance.Journal of cell science · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Non-lysine ubiquitylation: Doing things differently.Frontiers in molecular biosciences · 2022
    Review
  7. Review
  8. Review
  9. The Peroxisomal PTS1-Import Defect ofInternational journal of molecular sciences · 2020
    Article
  10. Article
  11. Ceramide regulates interaction of Hsd17b4 with Pex5 and function of peroxisomes.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Ubiquitin enzymes in the regulation of immune responses.Critical reviews in biochemistry and molecular biology · 2017
    Review
  17. Peroxisome protein import: a complex journey.Biochemical Society transactions · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Benjamin SchwartzkopffInstitut für Biochemie und Pathobiochemie, Abteilung für Systembiochemie, Medizinische Fakultät der Ruhr-Universität Bochum, D-44780 Bochum, Germany.
Harald W PlattaBiochemie Intrazellulärer Transportprozesse, Medizinische Fakultät der Ruhr-Universität Bochum, D-44780 Bochum, Germany.
Sohel HasanInstitut für Biochemie und Pathobiochemie, Abteilung für Systembiochemie, Medizinische Fakultät der Ruhr-Universität Bochum, D-44780 Bochum, Germany.
Wolfgang GirzalskyInstitut für Biochemie und Pathobiochemie, Abteilung für Systembiochemie, Medizinische Fakultät der Ruhr-Universität Bochum, D-44780 Bochum, Germany.
Ralf ErdmannInstitut für Biochemie und Pathobiochemie, Abteilung für Systembiochemie, Medizinische Fakultät der Ruhr-Universität Bochum, D-44780 Bochum, Germany Ralf.Erdmann@rub.de.
Ruhr University Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroxisomal matrix protein import is mediated by dynamic import receptors, which cycle between the peroxisomal membrane and the cytosol. Proteins with a type 1 peroxisomal targeting signal (PTS1) are bound by the import receptor Pex5p in the cytosol and guided to the peroxisomal membrane. After cargo translocation into the peroxisomal matrix, the receptor is released from the membrane back to the cytosol in an ATP-dependent manner by the AAA-type ATPases Pex1p and Pex6p. These mechanoenzymes recognize ubiquitinated Pex5p-species as substrates for membrane extraction. The PTS1-receptor is either polyubiquitinated via peptide bonds at two certain lysines and results in proteasomal degradation or monoubiquitinated via a thioester-bond at a conserved cysteine, which enables the recycling of Pex5p and further rounds of matrix protein import. To investigate the physiological relevance of the conserved N-terminal cysteine of Pex5p, the known target amino acids for ubiquitination were substituted by site-directed mutagenesis. In contrast with Pex5pC6A, Pex5pC6K turned out to be functional in PTS1 import and utilization of oleic acid, independent of the lysines at position 18 and 24. In contrast with wild-type Pex5p, Pex5pC6K displays an ubiquitination pattern, similar to the polyubiquitination pattern of Pex4p or Pex22p mutant strains. Moreover, Pex5pC6K displays a significantly reduced steady-state level when the deubiquitinating enzyme Ubp15p is missing. Thus, our results indicate that not the cysteine residue but the position of ubiquitination is important for Pex5p function. The presence of the cysteine prevents polyubiquitination and rapid degradation of Pex5p.

Indexed as

CysteineGene DeletionLysineMembrane Transport ProteinsPeroxinsPeroxisomesPeroxisome-Targeting Signal 1 ReceptorProteasome Endopeptidase ComplexProtein TransportProteolysisSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsUbiquitinationCysteineLysineMembrane Transport ProteinsPeroxinsPeroxisome-Targeting Signal 1 ReceptorPEX4 protein, S cerevisiaePEX5 protein, S cerevisiaeProteasome Endopeptidase ComplexSaccharomyces cerevisiae Proteinsperoxisome biogenesisPex5pprotein importtype 1 peroxisomal targeting signal (PTS1)-receptorubiquitination

Identifiers

PMID26182377
PMCPMC4613714
OpenAlexW2275451570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.